Smartphone ECG for heart attack detection
Part of Heart & circulation clinical trials.
This study tests whether a smartphone can take a 12-lead ECG (a heart tracing) quickly when someone arrives at the ER with chest pain, to help doctors spot a heart attack sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are having chest pain right now and went to the emergency room.
- You or a family member can sign a form agreeing to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a smartwatch can help alert doctors to heart problems early in people who recently had a heart attack and have high blood pressure. It aims to improve recovery and prevent future heart issues.
This trial tests whether a simple home electrocardiogram (ECG) can be used to check your heart function. It may help find people who have a weak heart pump without needing a full heart ultrasound right away.
This study tests a smartphone app that guides your recovery after a heart attack. The app helps with exercise and healthy habits, and you would either use the app or get usual care to see which works better.
This study tests if a smartphone app can help people with a chronic heart condition called coronary syndrome. It aims to make care easier and track symptoms at home.
This study is testing how well a smartwatch can detect a specific type of heart attack (STEMI) in people who come to the hospital with chest pain. It aims to see if the smartwatch's ECG feature is accurate compared to standard hospital tests.
This study tests a smartphone app that uses artificial intelligence (AI) to help prehospital care providers like you interpret electrocardiograms (ECGs), which are heart-rhythm recordings. If the app works well, it could help you make faster and more accurate decisions when caring for patients in the field.
Hear when a new Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.